Q4 2024 Holdings
Filed 2025-02-14 | 82 holdings | $393.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $35.8M | 397,505 | 9.1% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $31.2M | 13,680,554 | 7.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $27.6M | 631,176 | 7.0% |
| Atricure Inc(ATRC) | COM | 04963C209 | $19.6M | 641,673 | 5.0% |
| Merus N V | COM | N5749R100 | $19.0M | 451,804 | 4.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $18.7M | 398,100 | 4.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.2M | 103,355 | 3.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $14.0M | 846,882 | 3.5% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.6M | 102,500 | 3.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $13.1M | 149,763 | 3.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $12.8M | 498,827 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.7M | 273,739 | 2.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.8M | 71,615 | 2.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.3M | 731,363 | 2.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $8.2M | 220,235 | 2.1% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $8.0M | 223,208 | 2.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.2M | 542,002 | 1.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.9M | 811,678 | 1.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.2M | 492,515 | 1.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.1M | 65,552 | 1.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $5.0M | 667,000 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.0M | 187,140 | 1.3% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $4.4M | $4,000,000 | 1.1% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.4M | 1,441,029 | 1.1% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $4.2M | 1,567,561 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.9M | 448,368 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $3.8M | 254,217 | 1.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.6M | 130,175 | 0.9% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.5M | 120,700 | 0.9% |
| Insulet Corp(PODD) | COM | 45784P101 | $3.2M | 12,400 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.7M | 299,775 | 0.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.7M | 107,996 | 0.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $2.6M | 1,240,118 | 0.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.6M | 64,516 | 0.7% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $2.6M | 393,083 | 0.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $2.4M | 1,222,358 | 0.6% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $2.1M | 130,316 | 0.5% |
| Inogen Inc(INGN) | COM | 45780L104 | $1.9M | 208,790 | 0.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.9M | 171,097 | 0.5% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $1.8M | 105,500 | 0.5% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.8M | 193,208 | 0.5% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.8M | 146,500 | 0.5% |
| Immatics NV(IMTX) | SHS | N44445109 | $1.7M | 245,000 | 0.4% |
| Alector Inc(ALEC) | COM | 014442107 | $1.7M | 912,928 | 0.4% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.7M | 1,704,232 | 0.4% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.7M | 120,799 | 0.4% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.4M | 188,347 | 0.4% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $1.4M | 371,434 | 0.4% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.4M | 875,200 | 0.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.4M | 586,667 | 0.4% |